Prostate cancer is the most commonly diagnosed cancer in Australian men, with over 18,000 new cases each year. Men in Australia have a 1 in 5 chance of being diagnosed before the age of 85 and a 1 in 25 chance of dying from prostate cancer. This makes prostate cancer more common than any other type of cancer and more lethal than most other cancer types. Furthermore, the Australian Institute of Health and Welfare predict that incidence will increase by 50% by 2020. The high incidence, associated mortality and growing population burden make prostate cancer a health care priority in Australia. Prostate cancer treatments are varied and include: deferred treatment (active surveillance), watchful waiting, radical prostatectomy, radiotherapy or androgen deprivation therapy (ADT). SA-PCCOC is tracking men with prostate cancer across the state in order to compare outcomes of each treatment type. This research will provide an evidence base to help select the best treatment - in terms of survival and quality of life - for each man diagnosed with prostate cancer.
What we aim to achieve
If successful, this research will ensure that each patient with prostate cancer receives the best treatment possible in terms of survival and quality of life.
What are the next steps and milestones for your research?
Infrastructure support for SA-PCCOC will be used to implement automated and efficient data collection tools to enable complete population coverage.
What motivates you to pursue cancer research?
Research is the main way forward when it comes to improving the treatments we offer to patients with cancer.
Laboratory research often takes many, many years to translate into clinical practice.
Clinical outcomes research, particularly using high quality registries such as ours, can lead to patient care improvements in much shorter time frames, particularly once the registry is established and mature, as is the case with SA-PCCOC.
It’s been said…
SCIENCE tells us what we CAN DO
GUIDELINES tell us what we SHOULD DO
REGISTRIES tell us what we ARE ACTUALLY DOING!
Unlike the majority of treatment recommendations, developed from data sets which come from large, highly specialised, single centre, “ivory tower” academic institutions in the United States or Europe, SA-PCCOC provides support to the decision making processes of local physicians, policy makers and patients through the study of clinical, economic, and health related Quality of Life outcomes in men with prostate cancer treated in real world community settings, and more importantly, results specifically relevant to Australian prostate cancer patients and their carers.
Outcomes research can have an immediate impact, by alerting clinical staff where results are not as good as expected, or model those that exceed the average. It can also be instrumental in speeding up the translation of new treatment approaches into clinical practice and can potentially improve outcomes in a much shorter time frame compared to laboratory research.
My message to supporters:
We are very thankful for the contribution of the Beat Cancer Project towards SA-PCCOC. This funding helps to track the outcomes of men with prostate cancer across SA and to develop clinical tools ensuring that newly diagnosed men receive the best treatment possible.